One of the largest private multi-specialty tertiary care organisations operating in India’s North and East is Global Health Limited. Cardiology and cardiac science, neurosciences, oncology, digestive and hepatobiliary sciences, orthopaedics, liver transplant, kidney and urology are among the company’s key specialties.
- Global Health Limited reported Total Income for Q4 FY23 of ₹731.82 Crore up from ₹533.14 Crore year on year, a growth of 37.3%.
- Total Expenses for Q4 FY23 of ₹598.74 Crore up from ₹503.90 Crore year on year, a growth of 18.8%.
- Consolidated Net Profit of ₹101.07 Crore, up 476% from ₹17.54 Crore in the same quarter of the previous year.
- The Earnings per Share is ₹3.76, up from ₹0.69 in the same quarter of the previous year.